Skip to content

Clinical Trial of Chai Qin Qing Ning Capsule in the treatments of cold with fever

Chai Qin Qing Ning Capsule in the treatments of Cold with fever (wind-warm syndrome): a multicentre, double-blind, randomised, positive drug controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16009049
Enrollment
Unknown
Registered
2016-08-19
Start date
2016-01-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cold and Fever

Interventions

Treatment group :Chaiqin Qingning capsule
Control group :Qing Kailing capsule

Sponsors

LONGHUA Hospital Shanghai University of Traditional Chinese Medicine Medical
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Conforms to the diagnosis standard of western medicine of acute upper respiratory tract infection; 2. TCM syndrome of wind-warm syndrome; 3. Axillary temperature=37.5 degree C; 4. Aged 18 to 65 years old; 5. The course of the disease within 48 hours; 6. Voluntary and signed ICF.

Exclusion criteria

Exclusion criteria: 1. With chronic respiratory diseases, pneumonia, pharyngo conjunctivitis, acute exacerbation of chronic bronchitis, suppurative tonsillitis; 2. The blood WBC less than 4×10^9/L or greater than 11×10^9/L and/or neutrophil classification N%=80%; 3. With metabolic liver kidney and hematopoietic system diseases (diabetes, thyroid disease, adrenal disease), tumor; 4. Immunodeficiency disease, or the use of immunosuppressive agents in the past 3 months; 5. Preparation of pregnant women, pregnant women and lactating women; 6. Allergic constitution (refer to two or more drugs or food allergies or the trial use of known ingredients allergy); 7. Participated in clinical trials in the past 3 months; 8. Patients with mental illness, or no ability to know; 9. Other antibiotics, antipyretics or cold treatment taken before the first visit.

Design outcomes

Primary

MeasureTime frame
Antipyretic effect time;The time of body temperature to normal;

Secondary

MeasureTime frame
Fever and sore throat disappearance rate after treatment on the third day; Disease treatment effect;Curative effect of Chinese medicinal symptom;Curative effect of single symptom;The case use Antipyretic analgesic;

Countries

China

Contacts

Public ContactBangjiang Fang

LONGHUA Hospital Shanghai University of Traditional Chinese Medicine

fangbji@163.com+86 18917763257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026